Francis Willard Sarena - Net Worth and Insider Trading
Francis Willard Sarena Net Worth
The estimated net worth of Francis Willard Sarena is at least $3 Million dollars as of 2024-11-05. Francis Willard Sarena is the Chief Strategy Officer of Five Prime Therapeutics Inc and owns about 78,824 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $3 Million. Details can be seen in Francis Willard Sarena's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Francis Willard Sarena has not made any transactions after 2017-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Francis Willard Sarena
Francis Willard Sarena Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Francis Willard Sarena owns 4 companies in total, including Five Prime Therapeutics Inc (FPRX) , PDL BioPharma Inc (PDLI) , and Apexigen Inc (APGN) among others .
Click here to see the complete history of Francis Willard Sarena’s form 4 insider trades.
Insider Ownership Summary of Francis Willard Sarena
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2020-02-24 | Chief Strategy Officer |
| PDLI | PDL BioPharma Inc | 2008-09-15 | VP/Gen Counsel/Secy |
| APGN | Apexigen Inc | 2022-07-29 | Chief Operating Officer |
 | | 2022-07-29 | Chief Operating Officer |
Francis Willard Sarena Latest Holdings Summary
Francis Willard Sarena currently owns a total of 1 stock. Francis Willard Sarena owns 78,824 shares of Five Prime Therapeutics Inc (FPRX) as of January 18, 2017, with a value of $3 Million.
Latest Holdings of Francis Willard Sarena
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2017-01-18 | 78,824 | 38.00 | 2,995,312 |
Holding Weightings of Francis Willard Sarena
Francis Willard Sarena Form 4 Trading Tracker
According to the SEC Form 4 filings, Francis Willard Sarena has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the sale of 3,636 shares on January 18, 2017, which brought Francis Willard Sarena around $172,310.
Insider Trading History of Francis Willard Sarena
- 1
Francis Willard Sarena Trading Performance
Francis Willard Sarena Ownership Network
Ownership Network List of Francis Willard Sarena
Ownership Network Relation of Francis Willard Sarena
Francis Willard Sarena Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Francis Willard Sarena is the Chief Strategy Officer of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and 10 percent owner Bvf Partners L P/il .
Five Prime Therapeutics Inc (FPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
Francis Willard Sarena Mailing Address
Above is the net worth, insider trading, and ownership report for Francis Willard Sarena. You might contact Francis Willard Sarena via mailing address: C/o Five Prime Therapeutics, Inc., 2 Corporate Drive, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
